FINARO
11.3.2022 14:32:08 CET | Business Wire | Pressemeddelelse
Finaro (tidligere Credorax) , en global betalingsudbyder og Europæisk bank, der styrker international handel gennem teknologiske og enkle betalingsløsninger, har i dag offentliggjort, at de har indgået en aftale med Shift4 omkring salget af Finaro til en værdi af 575 millioner USD. Det kombinerede tilbud, fra begge virksomheder, skaber en positiv synergi af et globalt betalingsnetværk med en betydelig POS og eCommerce platform, på tværs af en bred vifte af vertikaler, der servicerer store og komplekse virksomheder med unikke løsninger. Sammen vil Finaro og Shift4 være bedre i stand til at forsyne virksomheder med globale betalingsløsninger gennem flere kanaler, og stå side om side med nogle af de største aktører i betalingsbranchen, heriblandt Adyen, Nuvei og WorldPay.
“Dette køb understreger vores offensive bestræbelser på, at levere en unified commerce oplevelse overalt i verden. Denne handel viser tydeligt vores evne til at støtte eksisterende transformerende og globale kunder, såsom SpaceX Starlink & St. Jude Children’s Research Hospital,” fortæller Shift4s CEO Jared Isaacman.
Finaro vil levere den globale infrastruktur og den nødvendige banebrydende teknologi, for at føre Shift4s internationale ambitioner ud i livet om at levere en unified commerce løsning. Ved at integrere Finaros kapaciteter, vil Shift4 være i stand til at udvide virksomhedens nuværende serviceydelser overalt i verden, inklusiv dens næste generation af SkyTab POS-løsning, Shift4Shop e-handelsplatform og VenueNext stadiontilbud. Shift4 har også mere end 425 softwareintegrationer og over 200.000 merchants, hvoraf mange har en multinational tilstedeværelse, og giver øjeblikkelige internationale muligheder, som der nu kan åbnes for som et resultat af denne nyerhvervelse.
“Denne erhvervelse understreger, at vi har opnået, hvad vi har sat os for at opnå – at opbygge pålidelige betalingsbehandlingskapaciteter, som i sandhed er uden grænser, både hvad angår tilgængelighed og størrelse. At kunne anvende denne teknologi til SpaceXs Starlink-program, og andre der er tilsvarende i størrelsen, samtidig med også at kunne tilbyde vores virksomheder og partnere overalt i verden et bredere udvalg af produkter og serviceydelser, er realiseringen af dette mål på den mest konkrete måde, og vi er begejstrede over at blive en del af Shift 4- teamet,” fortæller Igal Rotem, CEO for Finaro.
For yderligere information om denne nyerhvervelse, besøg venligst præsentationssektionen på Shift4s Investor Relations website her .
###
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20220311005243/da/
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
